Content
08/27/2024
San Francisco, CA USA
ZBiotics
completed $12 million Series A Round funding. Investors include
Spring Tide Capital (lead), Access Capital, Goat Rodeo Capital, Seamless Ventures, Seaside Ventures.
About
Zack Abbott, PhD microbiologist, founded ZBiotics because of the potential genetically engineered probiotics have to improve daily living. Our first product is a probiotic that helps you feel better the day after drinking alcohol.
ZBiotics is leveraging its patented technology to create a whole new category of products that help our bodies deal with whatever modern life throws our way.
It’s genetic engineering as it should be: transparent, responsible, and people first.
Startup
Sector:
Health & Wellness
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
